HHS Commercialization Transition Guidance

Centers for Disease Control and Prevention. (2023). HHS Commercialization Transition Guidance. (Accessed 07/12/2023.)
This guidance from HHS provides direction to those participating in the COVID-19 Vaccination Program as the USG stops distributing COVID-19 vaccines through its current ordering system and the vaccines transition to traditional pathways for procurement, distribution and payment of COVID-19 vaccines. Additional guidance from CDC will become available in the days ahead. The document also includes information on exceptional orders after full-scale ordering closes, guidance on inventory and disposal management of vaccine and ancillary supplies, data reporting requirements, CDC programs for uninsured individuals, anticipated vaccine schedule for fall, and planning considerations.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.